NFA
BIIB icon

Nuveen Fund Advisors’s Biogen BIIB Stock Holding History

Nuveen Fund Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-932
Closed -$271K – 126
2018
Q2 		$271K Sell
932
-1,115
-54% -$313K 0.33% 118
2018
Q1 		$561K Sell
2,047
-157
-7% -$48.7K 0.26% 117
2017
Q4 		$702K Sell
2,204
-2,791
-56% -$895K 0.2% 134
2017
Q3 		$1.56M Sell
4,995
-941
-16% -$279K 0.32% 94
2017
Q2 		$1.61M Sell
5,936
-3,339
-36% -$883K 0.26% 122
2017
Q1 		$2.54M Sell
9,275
-969
-9% -$274K 0.34% 103
2016
Q4 		$2.9M Sell
10,244
-895
-8% -$265K 0.42% 80
2016
Q3 		$3.49M Buy
11,139
+481
+5% +$142K 0.49% 56
2016
Q2 		$2.58M Buy
+10,658
New +$2.81M 0.4% 83

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nuveen Fund Advisors's BIIB Position: Q3 2018 in Review

Nuveen Fund Advisors sold out of Biogen (BIIB) in Q3 2018, closing a stake of 932 shares — an estimated $271K sold.

Nuveen Fund Advisors first reported a position in BIIB in Q2 2016 and held it in 9 quarters. The position peaked at $3.49M in Q3 2016. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Nuveen Fund Advisors reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 932 Biogen shares in Q3 2018, an estimated $271K.
  • Nuveen Fund Advisors first reported a position in Biogen in Q2 2016 and held it in 9 quarters.
  • Nuveen Fund Advisors's Biogen position peaked at $3.49M in Q3 2016.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Nuveen Fund Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.